Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KORU vs GSK✓SelectedUSD · GSKKORU vs GSK performance historyLatest closeAs of-5.42%11/13
Stock and ETF performance explorer

KORU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-36.9%
GSK return
+44.4%
Excess return
-81.3%
Maximum drawdown
-89.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.4%+0.5%-5.9%-5.6%
7D+11.1%+1.1%+10.0%+10.7%
30D-40.6%+6.3%-46.9%-42.2%
3M-63.9%+1.8%-65.7%-64.5%
6M-82.8%+1.7%-84.5%-83.6%
YTD-15.4%+6.5%-21.9%-21.0%
1Y-3.3%+9.5%-12.7%-11.0%
3Y+136.2%+65.3%+70.9%+60.3%
All-36.9%+44.4%-81.3%-59.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling